CORONA Remedies Ltd (CORONA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: CORONA | Pharmaceuticals & Drugs |

BSE Share Price
Not Listed

CORONA Remedies Ltd (CORONA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: CORONA | Pharmaceuticals & Drugs |

DeciZen - make an informed investing decision on CORONA Remedies

Based on:

DeciZen not available for IPO

10 Year X-Ray of CORONA Remedies:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 24.4%1.1%30%25.9%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 5766178841,0140
Sales YoY Gr.-7.2%43.2%14.8%-
Adj EPS 13.7-0.113.814.90
YoY Gr.--101%NA7.9%-
BVPS (₹) 66.162.966.778.50
Adj Net
Profit
69.8-0.784.391NAN
Cash Flow from Ops. 79.297.7103157-
Debt/CF from Ops. 0.60.400.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA20.8%14.8%
Adj EPS NANA2.8%7.9%
BVPSNANA5.9%17.7%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
20.7-0.223.120.50
Op. Profit
Mgn %
18.32.914.515.4NAN
Net Profit
Mgn %
12.1-0.19.59NAN
Debt to
Equity
0.20.100.3-
Working Cap
Days
01691151020
Cash Conv.
Cycle
05416130

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - CORONA Remedies Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray of CORONA Remedies:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of CORONA Remedies - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of CORONA Remedies

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Sales576.16617.33884.051,014.471,196.42
Operating Expenses 470.78599.51756.07859.74956.44
Manufacturing Costs2.547.3113.2117.8921.37
Material Costs144.47146.64210.95226.83236.51
Employee Cost 176.36226.66254.77295.37346.14
Other Costs 147.40218.90277.14319.65352.41
Operating Profit 105.3917.82127.98154.74239.98
Operating Profit Margin (%) 18.3%2.9%14.5%15.3%20.1%
Other Income 4.946.607.056.465.94
Interest 2.014.734.2714.4410.60
Depreciation 15.8920.4820.1028.2837.16
Exceptional Items 00000
Profit Before Tax 92.43-0.80110.66118.48198.15
Tax 22.49-0.4025.9627.9849.10
Profit After Tax 69.95-0.4084.7090.50149.05
PAT Margin (%) 12.1%-0.1%9.6%8.9%12.5%
Adjusted EPS (₹)13.7-0.313.914.824.4
Dividend Payout Ratio (%)0%-375%20%25%30%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 337.82320.91408.29480.18605.73
Share Capital 5.0351.0561.5561.1661.16
Reserves 332.80269.86346.75419.02544.57
Minority Interest00000
Debt36.5718.612.3398.1426.69
Long Term Debt31.8216.5406716
Short Term Debt4.752.072.3331.1410.69
Trade Payables72.0484.6094.37114.29143.52
Others Liabilities 137.77129.54157.44182.35240.81
Total Liabilities 584.21553.65662.43874.961,016.75

Fixed Assets

Gross Block196.04213.88256.34483.05502.59
Accumulated Depreciation31.6452.1271.7499.36132.71
Net Fixed Assets 164.40161.76184.60383.70369.88
CWIP 014.2364.71120.59185.95
Investments 36.8914.0631.2725.3125.33
Inventories30.6073.95105.4098.35129.48
Trade Receivables207.2174.3586.9999.93118.29
Cash Equivalents 43.32100.9876.7069.9069.27
Others Assets 101.80114.33112.7777.18118.55
Total Assets 584.21553.65662.43874.961,016.75

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 79.1697.71102.70156.76190.49
PBT 92.43-0.80110.66118.48198.15
Adjustment 28.8720.3422.7846.8752.69
Changes in Working Capital -14.5379.66-4.919.32-17.06
Tax Paid -27.61-1.50-25.82-17.91-43.28
Cash Flow From Investing Activity -102.12-65.78-50.25-266.65-83.84
Capex -44.65-34.01-93.81-285.77-91.01
Net Investments -28.80-40.4137.5914.462.76
Others -28.678.635.974.674.42
Cash Flow From Financing Activity 0.09-29.86-44.7598.54-106.59
Net Proceeds from Shares 00000
Net Proceeds from Borrowing 24.18-16.14-31.67103-51
Interest Paid -1.76-5.01-4.38-14.47-10.13
Dividend Paid 0-6.99-6.97-16.94-22.63
Others -22.32-1.71-1.7326.95-22.83
Net Cash Flow -22.862.077.71-11.340.07

Finance Ratio

PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)20.73-0.1223.2420.3827.45
ROCE (%)24.361.1130.0425.9432.55
Asset Turnover Ratio1.041.171.481.351.29
PAT to CFO Conversion(x)1.13N/A1.211.731.28
Working Capital Days
Receivable Days12442333333
Inventory Days1842363634
Payable Days182211155168199

CORONA Remedies Ltd Stock News

CORONA Remedies Ltd FAQs

The current trading price of CORONA Remedies on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of CORONA Remedies stood at ₹0.00.
The latest P/E ratio of CORONA Remedies as of 31-Dec-1969 is 0.00.
The latest P/B ratio of CORONA Remedies as of 31-Dec-1969 is 0.00.
The 52-week high of CORONA Remedies is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of CORONA Remedies is ₹0.00 ( Cr.) .

About CORONA Remedies Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×